Please enter the password you have been provided with to access this content on IPFzone.com

If you do not have the password please contact your local Roche affiliate.

You may wish to sign up for the IPFzone.com newsfeed to recieve regular updates on IPF news via email

  • Step 1
  • Step 2
  • Step 3
  • Step 4
  • Step 5

Welcome to IPFzone.com

This educational website is intended for use by healthcare professionals in countries where pirfenidone is approved , outside of the US and UK.

Please confirm you are a healthcare professional outside the UK and the US to continue to IPFzone.com

I confirm I am a healthcare professional

If you are not a healthcare professional, please visit Roche.com/respiratory which contains IPF-related information intended for the general public

You are now leaving www.IPFzone.com

By following this link you will be leaving the www.IPFzone.com website.

Please note that Roche does not take responsibility for the content displayed on other websites

It appears you are in a country where pirfenidone is not approved

I am a healthcare professional practising in a country where pirfenidone has been approved and wish to continue to IPFzone.com

I am a healthcare professional practising in a country where pirfenidone has not been approved and would like to visit Roche.com/respiratory which contains IPF-related information intended for the general public

You are now leaving www.IPFzone.com

By following this link you will be leaving the www.IPFzone.com website.

Please note that Roche does not take responsibility for the content displayed on other websites.